Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| MOH/ oman | Other Identifier | MOH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam & Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| midazolame $ fentanyl | Other | use as compare between two group |
|
| dexetomidate | Other | use as compare to other group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| atomizer | Device | use atomizer to provide the medication in procedure sedation |
|
| Measure | Description | Time Frame |
|---|---|---|
| depth of sedtion | using MOAA/S score, Modified Observer's Assessment of Alertness/Sedation Scale , as 0 high score for deep sedation, 5 not in deep sedation | 1 year |
Not provided
Not provided
Inclusion Criteria:
inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ghaliy khamis al noofli, MD | Contact | +96895751564 | r23029@resident.omsb.org | |
| ahoud abdullah al saidi, MD | Contact | +96892903021 | r23031@resident.omsb.org |
| Name | Affiliation | Role |
|---|---|---|
| saud al bulashi, MD | MOH/ oman | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| dr.Suad al baluish | Muscat | Oman |
Not provided
Not provided
Not provided
Not provided
Not provided
| rescue medication | Drug | will be used as rescue if the atomizer medication not fully sedated |
|
| Midazolam | Drug | Intranasal administration for procedural sedation. |
|
| fentanyl | Drug | Intranasal administration for procedural sedation. |
|
| Dexmedetomidine | Drug | Intranasal administration for procedural sedation. |
|
| Placabo | Drug | use atomizer to provide the placebo in procedure sedation |
|
| ID | Term |
|---|---|
| D009330 | Nebulizers and Vaporizers |
| D008874 | Midazolam |
| D005283 | Fentanyl |
| D020927 | Dexmedetomidine |
| ID | Term |
|---|---|
| D004864 | Equipment and Supplies |
| D001569 | Benzodiazepines |
| D001552 | Benzazepines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D010880 | Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D007093 | Imidazoles |
| D001393 | Azoles |
Not provided
Not provided